Nappi Carmela, Ponsiglione Andrea, Vallone Carlo, Lepre Roberto, Basile Luigi, Green Roberta, Cantoni Valeria, Mainolfi Ciro Gabriele, Imbriaco Massimo, Petretta Mario, Cuocolo Alberto
Department of Advanced Biomedical Sciences, University Federico II, 80131 Naples, Italy.
IRCCS Synlab SDN, 80143 Naples, Italy.
J Cardiovasc Dev Dis. 2024 Oct 17;11(10):331. doi: 10.3390/jcdd11100331.
Whole-body positron emission tomography (PET)-computed tomography (CT) imaging performed for oncological purposes may provide additional parameters such as the coronary artery calcium (CAC) and epicardial adipose tissue (EAT) volume with cost-effective prognostic information in asymptomatic people beyond traditional cardiovascular risk factors. We evaluated the feasibility of measuring the CAC score and EAT volume in cancer patients without known coronary artery disease (CAD) referred to whole-body F-FDG PET-CT imaging, regardless of the main clinical problem. We also investigated the potential relationships between traditional cardiovascular risk factors and CAC with EAT volume. A total of 109 oncological patients without overt CAD underwent whole-body PET-CT imaging with F-fluorodeoxyglucose (FDG). Unenhanced CT images were retrospectively viewed for CAC and EAT measurements on a dedicated platform. Overall, the mean EAT volume was 99 ± 49 cm. Patients with a CAC score ≥ 1 were older than those with a CAC = 0 ( < 0.001) and the prevalence of hypertension was higher in patients with detectable CAC as compared to those without ( < 0.005). The EAT volume was higher in patients with CAC than in those without ( < 0.001). For univariable age, body mass index (BMI), hypertension, and CAC were associated with increasing EAT values (all < 0.005). However, the correlation between the CAC score and EAT volume was weak, and in multivariable analysis only age and BMI were independently associated with increased EAT (both < 0.001), suggesting that potential prognostic information on CAC and EAT is not redundant. This study demonstrates the feasibility of a cost-effective assessment of CAC scores and EAT volumes in oncological patients undergoing whole-body F-FDG PET-CT imaging, enabling staging cancer disease and atherosclerotic burden by a single test already included in the diagnostic work program, with optimization of the radiation dose and without additional costs.
为肿瘤学目的进行的全身正电子发射断层扫描(PET)-计算机断层扫描(CT)成像,除了传统心血管危险因素外,还可为无症状人群提供诸如冠状动脉钙化(CAC)和心外膜脂肪组织(EAT)体积等额外参数,以及具有成本效益的预后信息。我们评估了在接受全身F-FDG PET-CT成像的、无已知冠状动脉疾病(CAD)的癌症患者中测量CAC评分和EAT体积的可行性,无论其主要临床问题是什么。我们还研究了传统心血管危险因素与CAC和EAT体积之间的潜在关系。共有109例无明显CAD的肿瘤患者接受了F-氟脱氧葡萄糖(FDG)全身PET-CT成像。在一个专用平台上对未增强的CT图像进行回顾性观察,以测量CAC和EAT。总体而言,EAT的平均体积为99±49 cm。CAC评分≥1的患者比CAC = 0的患者年龄更大(<0.001),与无CAC的患者相比,可检测到CAC的患者高血压患病率更高(<0.005)。有CAC的患者的EAT体积高于无CAC的患者(<0.001)。单变量分析中,年龄、体重指数(BMI)、高血压和CAC与EAT值增加相关(均<0.005)。然而,CAC评分与EAT体积之间的相关性较弱,多变量分析中只有年龄和BMI与EAT增加独立相关(均<0.001),这表明关于CAC和EAT的潜在预后信息并非多余。本研究证明了在接受全身F-FDG PET-CT成像的肿瘤患者中,对CAC评分和EAT体积进行具有成本效益评估的可行性,通过诊断工作程序中已包含的单一检查即可对癌症疾病和动脉粥样硬化负担进行分期,同时优化辐射剂量且无需额外费用。